Coyote It IS being scientifically tested around the world.. Just NOT "blind or double blind" clinical trials.. The scientific "replication" factor is THERE.. And that's a major step to proving anything..
Here are 6300 testimonials as to the efficacy... REALIZE that some drugs on the market only WORK for as low as 40% of cases... All FDA approved.. Even important ones like the "colon cancer in a box" one has a reliability of 80%... Which means that 5 to 10% of people who have colon cancer WONT BE CAUGHT with it..
Here's the testimonials..
Here are 6300 testimonials as to the efficacy... REALIZE that some drugs on the market only WORK for as low as 40% of cases... All FDA approved.. Even important ones like the "colon cancer in a box" one has a reliability of 80%... Which means that 5 to 10% of people who have colon cancer WONT BE CAUGHT with it..
Here's the testimonials..
Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context
Widespread confusion, conflicting reports, inconsistent testing, and off-indication use of existing and experimental drugs has resulted in no single source of information from the frontlines. To create a centralized and dynamic knowledge base, Sermo, the largest global healthcare polling company...
news.yahoo.com
- Hydroxychloroquine usage amongst COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the U.S., 17% in Germany, 16% in Canada, 13% in the UK, and 7% in Japan
- Hydroxychloroquine was overall chosen as the most effective therapy amongst COVID-19 treaters from a list of 15 options. (37% of COVID-19 treaters)
- 75% in Spain, 53% Italy, 44% in China, 43% in Brazil, 29% in France, 23% in the U.S., and 13% in the UK
- The two most common treatment regimens for Hydroxychloroquine were:
- (38%) 400mg twice daily on day one; 400 mg daily for five days
- (26%) 400mg twice daily on day one; 200mg twice daily for four days
- Outside the U.S., Hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients
- Globally, 19% of physicians prescribed or have seen Hydroxychloroquine prophylactically used for high risk patients, and 8% for low risk patients
Last edited: